New shot could stop HAE attacks in their tracks
Disease control
Recruiting now
This study tests a new medicine called navenibart to see if it can prevent the sudden, painful swelling attacks that people with hereditary angioedema (HAE) experience. About 145 adults and teenagers with HAE type 1 or 2 will receive either navenibart or a placebo injection for 6…
Phase: PHASE3 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC